ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 783

$1.18M Total Retail Price of All Prescriptions

Rank: 28 out of 783

875 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 875 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 875 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 19,298 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,047 983 1 1
AMLODIPINE BESYLATE 979 907 2 5
FUROSEMIDE 766 723 3 7
OMEPRAZOLE 741 679 4 6
HYDROCHLOROTHIAZIDE 674 618 5 12
SIMVASTATIN 673 631 6 3
LISINOPRIL 653 584 7 4
METFORMIN HCL 496 450 8 8
PRAVASTATIN SODIUM 485 405 9 14
HYDROCODONE-ACETAMINOPHEN 453 381 S3 10 2
WARFARIN SODIUM 444 416 11 10
METOPROLOL TARTRATE 406 380 12 9
METOPROLOL SUCCINATE 378 357 13 13
POTASSIUM CHLORIDE 369 354 14 16
TRAMADOL HCL 347 343 15 20
ATORVASTATIN CALCIUM 326 317 16 11
ALLOPURINOL 321 308 17 31
LOSARTAN POTASSIUM 298 266 18 18
ATENOLOL 293 286 19 17
GLIMEPIRIDE 283 273 20 34
ALENDRONATE SODIUM 265 253 21 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 247 227 22 33
SERTRALINE HCL 225 200 23 22
CITALOPRAM HBR 210 190 24 19
LOSARTAN-HYDROCHLOROTHIAZIDE 206 195 25 53
GABAPENTIN 205 124 26 15
LANTUS 186 161 27 38
CYMBALTA 183 150 28 35
CLOPIDOGREL 182 176 29 29
SYNTHROID 177 155 30 47
ISOSORBIDE MONONITRATE ER 168 168 31 40
CRESTOR 163 159 32 27
NEXIUM 162 114 33 28
ZOLPIDEM TARTRATE 160 144 34 23
CARVEDILOL 160 152 34 21
PLAVIX 138 126 36 51
TAMSULOSIN HCL 134 103 37 26
DONEPEZIL HCL 133 133 38 24
MELOXICAM 133 128 38 37
FLUTICASONE PROPIONATE 132 108 40 46
SPIRONOLACTONE 124 119 41 57
PANTOPRAZOLE SODIUM 122 111 42 30
DIOVAN 120 106 43 49
KLOR-CON M20 110 104 44 48
TORSEMIDE 106 106 45 126
PREDNISONE 102 90 46 36
AGGRENOX 100 100 47 196
POLYETHYLENE GLYCOL 3350 92 90 48 43
FLUOXETINE HCL 92 70 48 45
PAROXETINE HCL 92 86 48 69
FENTANYL 87 74 S2 51 65
JANUVIA 86 81 52 73
PROAIR HFA 86 65 52 56
AMOX TR-POTASSIUM CLAVULANATE 82 71 54 128
TRIAMCINOLONE ACETONIDE 82 78 54 151
QUINAPRIL HCL 77 72 56 195
CELEBREX 75 75 57 93
NAMENDA 75 75 57 32
TRAZODONE HCL 74 58 59 39
INSULIN SYRINGE 73 60 60 82
VERAPAMIL ER 72 72 61 119
EVISTA 72 72 61 92
NADOLOL 65 61 63 265
LYRICA 64 61 64 98
CLONIDINE HCL 62 61 65 60
TRIAMTERENE-HCTZ 61 45 66 42
NIFEDIPINE ER 61 50 66 135
FELODIPINE ER 60 44 68 221
PEN NEEDLE 59 52 69 103
SPIRIVA 58 49 70 59
CIPROFLOXACIN HCL 54 53 71 62
AZITHROMYCIN 53 47 72 41
DILTIAZEM 24HR ER 53 40 72 122
FENOFIBRATE 52 45 74 66
HUMALOG 51 39 75 101
KLOR-CON 10 51 51 75 102
BYSTOLIC 51 51 75 99
GLYBURIDE 50 38 R 78 111
ESCITALOPRAM OXALATE 50 44 78 54
DIGOXIN 50 50 78 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.